NO20051641L - Improved imaging agents comprising barbituric acid derivatives - Google Patents

Improved imaging agents comprising barbituric acid derivatives

Info

Publication number
NO20051641L
NO20051641L NO20051641A NO20051641A NO20051641L NO 20051641 L NO20051641 L NO 20051641L NO 20051641 A NO20051641 A NO 20051641A NO 20051641 A NO20051641 A NO 20051641A NO 20051641 L NO20051641 L NO 20051641L
Authority
NO
Norway
Prior art keywords
imaging
imaging agents
barbituric acid
acid derivatives
improved imaging
Prior art date
Application number
NO20051641A
Other languages
English (en)
Norwegian (no)
Inventor
Klaus Kopka
Hans-Jorg Breyholz
Stefan Wagner
Michael Schafers
Bodo Levkau
Benedictc Guilbert
Duncan Wynn
Original Assignee
Amersham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Plc filed Critical Amersham Plc
Publication of NO20051641L publication Critical patent/NO20051641L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20051641A 2002-10-08 2005-04-04 Improved imaging agents comprising barbituric acid derivatives NO20051641L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0223249.4A GB0223249D0 (en) 2002-10-08 2002-10-08 Improved imaging agents
PCT/GB2003/004351 WO2004032936A1 (en) 2002-10-08 2003-10-08 Improved imaging agents comprising barbituric acid derivatives

Publications (1)

Publication Number Publication Date
NO20051641L true NO20051641L (no) 2005-06-02

Family

ID=9945439

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051641A NO20051641L (no) 2002-10-08 2005-04-04 Improved imaging agents comprising barbituric acid derivatives

Country Status (10)

Country Link
US (1) US20060120956A1 (https=)
EP (1) EP1549317A1 (https=)
JP (1) JP2006505550A (https=)
CN (1) CN1720050A (https=)
AU (1) AU2003273505B2 (https=)
CA (1) CA2501136A1 (https=)
GB (1) GB0223249D0 (https=)
NO (1) NO20051641L (https=)
RU (1) RU2005109272A (https=)
WO (1) WO2004032936A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006021495A1 (de) * 2006-05-09 2007-11-15 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit
GB0612333D0 (en) * 2006-06-21 2006-08-02 Ge Healthcare Ltd Radiopharmaceutical products
CA2654369C (en) 2006-06-21 2014-10-14 Ge Healthcare Limited Radiopharmaceutical products
ATE551073T1 (de) * 2007-05-16 2012-04-15 Ge Healthcare As Markierte hgf-bindende peptide für bildgebung
GB0718386D0 (en) * 2007-09-21 2007-10-31 Ge Healthcare As Improved radiopharmaceutical formulation
GB201115937D0 (en) 2011-09-14 2011-10-26 Univ Aberdeen 18F-labelled compounds for use as positron emission imaging agents
WO2020039088A2 (en) * 2018-08-24 2020-02-27 Xeniopro GmbH Novel compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952971A (en) * 1971-11-09 1976-04-27 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Airfoil shape for flight at subsonic speeds
US3952091A (en) * 1974-10-23 1976-04-20 Hoffmann-La Roche Inc. Simultaneous multiple radioimmunoassay
GB1527416A (en) * 1976-07-20 1978-10-04 Ciba Geigy Ag Photopolymerisible diepoxides
US6472227B1 (en) * 1986-06-04 2002-10-29 Abbott Laboratories Barbiturate assay, tracers, immunogens, antibodies and kit
US5102786A (en) * 1987-05-21 1992-04-07 Pb Diagnostic Systems, Inc. Biological diagnostic assay system
CA2332277A1 (en) * 1998-05-15 1999-11-25 Nycomed Amersham Plc Labelled glutamine and lysine analogues
US6656448B1 (en) * 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
WO2001092244A1 (en) * 2000-05-30 2001-12-06 Wayne State University Inhibitors of matrix metalloproteinases
IL154946A0 (en) * 2000-10-26 2003-10-31 Pfizer Prod Inc Pyrimidine-2,4,6-trione metalloproteinase inhibitors
BR0114913A (pt) * 2000-10-26 2003-07-01 Pfizer Prod Inc Inibidores de metaloproteinase de espiro-pirimidina-2,4,6-triona
CN100336521C (zh) * 2000-12-12 2007-09-12 血管实验室公司 蜜蜂花叶提取物制备抑制血管生成相关疾病药物的用途
GB0115929D0 (en) * 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase electrophilic fluorination

Also Published As

Publication number Publication date
CA2501136A1 (en) 2004-04-22
CN1720050A (zh) 2006-01-11
WO2004032936A1 (en) 2004-04-22
AU2003273505B2 (en) 2007-04-19
AU2003273505A1 (en) 2004-05-04
GB0223249D0 (en) 2002-11-13
US20060120956A1 (en) 2006-06-08
RU2005109272A (ru) 2006-01-27
EP1549317A1 (en) 2005-07-06
JP2006505550A (ja) 2006-02-16

Similar Documents

Publication Publication Date Title
BRPI0411055A (pt) compostos de heteroarilas contendo nitrogênio e seus usos no aumento da eritropoietina endógena
IL178128A0 (en) Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same
BR9611533A (pt) Lipopoliamina composição e utilização e processo de preparação de uma lipopoliamina
WO2005053752A3 (en) Novel imaging agents comprising caspase-3 inhibitors
AR024516A1 (es) Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica.
DE3773237D1 (de) Einen makrozyklischen koordinat und einen antikoerper enthaltende konjugatverbindung.
WO2001092283A3 (en) Cobalamin compounds useful as cardiovascular agents and as imaging agents
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
FR2909284B1 (fr) Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
DK0702570T3 (da) Technetium-99m-mærkede peptider til afbildning af inflammation
DK1404377T3 (da) Forbedrede chelatorkonjugater
NO20051641L (no) Improved imaging agents comprising barbituric acid derivatives
EP2316493A3 (en) Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
DE502005010427D1 (de) Physiologisch aktive zusammensetzung gegen diabetes
IL192190A0 (en) Process for the preparation of pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid
EP1968542A4 (en) SOLID DISPERSION USING A LOW MELT ACTIVE SUBSTANCE AND ORAL ADMINISTRATIVE AGENT
DK1603598T3 (da) Radiomærkede konjugater baseret på substans P og anvendelser heraf
AU2002350950A1 (en) Compounds for imaging alzheimer's disease
NO20051811D0 (no) Conjugates of TC complexes and targeting moiettes and their use in mri diagnostic
ECSP045372A (es) Inhibidores de la carboxipeptidasa b plasmática
DK1359943T3 (da) Biotinderivater og deres konjugater med chelateringsmidler
ATE321754T1 (de) 2-substituierte 1,2,3,4-tetrahydrochinoline und derivate davon, zusammensetzungen und verfahren
BRPI0414512A (pt) reprodução de imagens e terapia de células beta pancreáticas, direcionadas por um mecanismo
AR046212A1 (es) Derivados de 2-fenilbenzofurano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
EP1048302A3 (en) Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application